James C. Mullen - 03 Jan 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
CEO, Director
Signature
/s/ James C. Mullen
Issuer symbol
EDIT
Transactions as of
03 Jan 2022
Net transactions value
-$491,979
Form type
4
Filing time
04 Jan 2022, 15:23:15 UTC
Previous filing
23 Dec 2021
Next filing
18 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $491,979 -18,252 -19% $26.95 75,898 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 22, 2021. The sale does not represent a discretionary trade by the Reporting Person.